Cyclerion Therapeutics, Inc. Gains 311.61%
Wed, Apr 01, 2026 at 07:29 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) jumped higher at $6.38, a gain of 311.6%. On Wed, Apr 01, 2026, CYCN:NASDAQ hit a New 2-Week High of $6.38. The stock appeared on our News Catalysts scanner on Wed, Apr 01, 2026 at 08:44 AM in the 'AGREEMENT' category. From Wed, Mar 18, 2026, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Apr 01, 2026 at $8.48 with a volume of 252M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 311.61%
- PMGC Holdings Inc. (ELAB:NASDAQ), 133.72%
- Axe Compute Inc. (AGPU:NASDAQ), 117.07%
- Mega Fortune Company Limited (MGRT:NASDAQ), 90.03%
- System1, Inc. (SST:NYSE), 72.85%
- RYTHM Inc Com Par $0.001 (New) (RYM:NASDAQ), 63.93%
- U Power Limited (UCAR:NASDAQ), 58.68%
- RenX Enterprises Corp Com (New) (RENX:NASDAQ), 46.63%
- Texxon Holding Limited (NPT:NASDAQ), 46.26%
- Intercont (Cayman) Limited (NCT:NASDAQ), 43.81%